Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cell-Surface Vimentin (CSV) Mouse anti-Human, PE, Clone:84-1, Abnova™

PE conjugated mouse monoclonal antibody recognizes human cell-surface vimentin (CSV).

Supplier:  Abnova Corporation H00007431MP08

Catalog No. 89-333-866


Only null left
Add to Cart

Description

Description

This gene encodes a member of the intermediate filament family. Intermediate filamentents, along with microtubules and actin microfilaments, make up the cytoskeleton. The protein encoded by this gene is responsible for maintaining cell shape, integrity of the cytoplasm, and stabilizing cytoskeletal interactions. It is also involved in the immune response, and controls the transport of low-density lipoprotein (LDL)-derived cholesterol from a lysosome to the site of esterification. It functions as an organizer of a number of critical proteins involved in attachment, migration, and cell signaling. Mutations in this gene causes a dominant, pulverulent cataract
Specifications

Specifications

Cell-Surface Vimentin (CSV)
Monoclonal
PE
PBS with no preservative; pH 7.4
P08670
VIM
Human recombinant vimentin
50 μg
Primary
Human
Antibody
IgG2b κ
Flow Cytometry, Immunofluorescence
84-1
vimentin
VIM
FLJ36605
Mouse
Affinity chromatography
RUO
7431
Store at 4°C in the dark. Aliquot to avoid repeated freezing and thawing.
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.